In the world of AAS, "mild" is a relative term. Compared to trenbolone, Superdrol, or Halotestin, Anavar and Primobolan are indeed gentle. They produce fewer side effects, less hepatotoxicity, and more manageable blood work changes. But "mild" does not mean "no monitoring" — and assuming these compounds are harmless on blood work is a mistake that can lead to cumulative health issues.
The most common error we see with these compounds is under-monitoring. Athletes assume that because the compounds are mild, their blood work will be unchanged. They skip mid-cycle blood draws, ignore their lipid panel, and then are surprised when they discover their HDL has dropped by 30 points or their E2 has crashed. The truth is that Anavar and Primobolan have specific, predictable effects that require targeted monitoring.
Anavar Blood Work Profile
Oxandrolone (Anavar) is widely considered the safest oral AAS, and this reputation is largely deserved. At typical doses (20-40 mg/day for men, 5-20 mg/day for women), its side effect profile is mild. But "safe" is contextual, and three markers deserve specific attention:
HDL Cholesterol
The key distinction with Anavar is that its liver enzyme elevation is almost always muscle-derived, not hepatic. Because Anavar is 17α-alkylated, some liver stress is theoretically possible, but GGT elevation on Anavar is rare at doses below 80 mg/day. If your AST and ALT are elevated on Anavar but GGT is normal, the source is almost certainly muscle leak — check your CK to confirm.
One often overlooked aspect of Anavar is its effect on creatinine. Anavar can cause a small but real increase in serum creatinine through increased muscle breakdown and renal load. This is typically benign and reverses upon discontinuation, but it can confuse eGFR calculations. If possible, include cystatin C in your mid-cycle blood work to distinguish muscle-mass-driven creatinine elevation from true renal stress.
Primobolan Blood Work Profile
Metenolone (Primobolan) is unique among injectable AAS for its exceptionally mild side effect profile. It does not aromatize, has minimal impact on lipids at moderate doses, and produces no significant hepatotoxicity because it is not 17α-alkylated (the injectable form is not orally bioavailable, so it does not need the modification).
The evidence suggests that Primobolan at doses up to 400 mg/week has minimal impact on HDL. Above 400 mg/week, the effect becomes measurable — HDL typically drops by 10-20% at 400-600 mg/week, which is still mild compared to most orals but is no longer negligible.
Estradiol (E2)
Why Primo Suppresses E2
The "Primo effect" on estrogen is one of the most under-appreciated aspects of this compound. Unlike masteron, which is a direct AR agonist with anti-estrogenic properties, Primobolan appears to suppress E2 through a different mechanism — possibly by reducing substrate availability for aromatase or by directly inhibiting the enzyme.
The practical consequence: if you add 400-600 mg of Primobolan to your cycle, even with 300-500 mg of testosterone, your E2 may drop significantly. Some users report E2 in the 5-10 pg/mL range on a test/Primo cycle — low enough to cause joint pain, libido loss, and mood flattening.
The Test/Primo E2 Strategy
Anavar vs. Primobolan: Blood Work Comparison
Here is how the two compounds compare across the markers that matter most:
Anavar vs Primobolan Blood Work Profile
| Marker | Anavar (Oxandrolone) | Primobolan (Metenolone) |
|---|---|---|
| HDL Impact | 25-50% drop — significant even at low doses | Minimal at ≤400 mg/wk, 10-20% at higher doses |
| Liver Stress | Mild — GGT elevation rare at ≤80 mg/day | None — injectable, no 17α-alkylation |
| E2 Impact | None — does not affect aromatase | Significant — suppresses E2 even with adequate test |
| Creatinine Effect | Small rise possible | None |
| Kidney Stress | Minimal, monitor cystatin C at high doses | Minimal |
| Unique Monitoring | HDL + GGT + cystatin C | E2 (sensitive assay) + HDL at high doses |
| Cardiovascular Load | Moderate (HDL-mediated) | Low |
| Risk Profile | Low but not zero — monitor HDL and GGT | Very low — monitor E2 carefully |